Aim of the journal

MedComm is a peer-reviewed, online open access journal that publishes the pioneer works providing novel insights into all aspects of medicine on the basis of novelty, timeliness and significance to human health. The journal emphasizes original findings that advance the understanding of pathogenesis or improve the diagnosis and treatment of human disease. Interdisciplinary studies utilizing approaches of molecular biology, cell biology, chemistry, pharmacology or material science to address the issues of clinical, basic and translational medicines are particularly encouraged.

Scope and topics (including keywords)

MedComm is interested in topics including but not limited to clinical medicine, molecule diagnostics, epigenetics/genetics, cell biology, drug discovery, nanotechnology and artificial intelligence. The journal focuses on clinical and experimental advances on disease characteristics, pathogenic mechanism and medical techniques.

Topics of interest include, but are not limited to:

• Epigenetics, genomics, proteomics and metabonomics
• Non-coding RNA in disease
• Cell senescence and cell death
• Cellular signal transduction
• Gene therapy and gene editing
• Cancer immunology and immunotherapy
• Structural biology, chemical genomics and drug discovery
• High-definition imaging
• Artificial intelligence in medicine
• Stem cells and regenerative medicine
• Nanomedicine and drug delivery system
• Early disease diagnosis and biomarkers
• Clinical trials evaluating new treatments for cancer or other diseases